e-learning
resources
Berlin 2001
Sunday 23.09.2001
Genetics and cell biology of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Flow cytometric DNA ploidy analysis of the lung cancer during chemotherapy
R. M. Mroz, E. Chyczewska, A. Holownia, T. Izycki, L. Chyczewski, J. J. Braszko (Bialystok, Poland)
Source:
Annual Congress 2001 - Genetics and cell biology of lung cancer
Session:
Genetics and cell biology of lung cancer
Session type:
Oral Presentation
Number:
239
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. M. Mroz, E. Chyczewska, A. Holownia, T. Izycki, L. Chyczewski, J. J. Braszko (Bialystok, Poland). Flow cytometric DNA ploidy analysis of the lung cancer during chemotherapy. Eur Respir J 2001; 16: Suppl. 31, 239
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006
Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in pleural effusion and ascitis
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010
Flow cytometric analysis of bronchoalveolar lavage leukocytes in COPD-patients after radiation exposure
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001
Blood flow cytometric analysis in stable asthmatics
Source: Eur Respir J 2005; 26: Suppl. 49, 589s
Year: 2005
Flow cytometric analysis of lymphocyte profiles in mediastinal lymph nodes
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Flow cytometry-based profiling of immune cells in asthmatic sputum
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
Real-time PCR analysis of free-circulating DNA in plasma of non-small cell lung cancer patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
Flow cytometric assessment of sputum lymphocyte cytokine profiles in patients with asthma and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001
Flow cytometry vs. immunohistochemistry in determining CD4+/CD8+ cell ratio in BAL fluid from patients with interstitial lung diseases
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Detection of lung cancer micrometastases in lymph nodes aspirates by flow cytometry.
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
Flow cytometric analysis of T cells maturation markers in mediastinal lymph nodes in sarcoidosis.
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
Comparative gene expression analysis in lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Assessment of DNA ploidy and proliferating activity changes in neoplasmatic cells according to TNM classification and clinical stages in non-small cell lung cancer (NSCLC) patients during chemotherapy
Source: Eur Respir J 2003; 22: Suppl. 45, 225s
Year: 2003
Effect of freezing of sputum samples on flow cytometric analysis of lymphocyte subsets
Source: Eur Respir J 2004; 24: 309-312
Year: 2004
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis
Source: ERJ Open Res, 5 (4) 00179-2019; 10.1183/23120541.00179-2019
Year: 2019
Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Evaluation by immunohistochemistry of EGF-R expression before and after chemotherapy in non small cell lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005
Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer?: Evaluation of quantitative semi-automated sputum cytometry on radon- and uranium-exposed workers
Source: Eur Respir J 2001; 18: 942-950
Year: 2001
Proteomic analysis of human small cell lung cancer tissues
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
High-dimensional mass cytometry analysis of immune cells in emphysematous lung tissue
Source: Virtual Congress 2020 – Cellular involvement in lung injury
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept